+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Isothermal Nucleic Acid Amplification Technology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 240 Pages
  • September 2025
  • Region: Global
  • Fairfield Market Research
  • ID: 5934372
The publisher has recently released a comprehensive report on the global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

The global isothermal nucleic acid amplification technology market size is likely to be valued at US$ 6.9 Bn in 2025 and is estimated to reach US$ 16.3 Bn by 2032, growing at a CAGR of 13.07% during 2025-2032.

Market Insights

The isothermal nucleic acid amplification technology market encompasses a range of advanced molecular diagnostic techniques designed to amplify nucleic acids at a constant temperature without the need for thermal cycling. INAAT technologies have emerged as faster, cost-effective, and highly sensitive alternatives to traditional PCR methods. Their application in infectious disease diagnostics, cancer detection, and blood screening continues to expand rapidly, supported by increasing healthcare demand for early, accurate, and portable diagnostic tools. Growing adoption across hospitals, diagnostic laboratories, and point-of-care testing environments is expected to sustain robust growth in the coming years.

Market Growth Drivers

Several factors are propelling the growth of the INAAT market. Rising prevalence of infectious diseases, including emerging viral outbreaks, has significantly increased the demand for rapid molecular diagnostics. The portability and speed of INAAT technologies make them especially suitable for point-of-care and resource-limited settings. Increasing R&D investments by biotechnology companies and growing adoption in blood screening and oncology testing are fueling demand. Moreover, the affordability of INAAT compared to conventional PCR tests makes it accessible in developing markets, further driving expansion.

Market Restraints

Despite strong growth potential, the market faces certain challenges. Limited awareness of advanced INAAT solutions in low-income countries hampers adoption. The presence of well-established PCR-based technologies creates competitive pressure, slowing the shift toward INAAT. Additionally, stringent regulatory requirements for diagnostic approvals can delay commercialization of new products. Technical limitations, such as specificity issues in certain assays, and the need for trained personnel in some applications may also restrict broader market penetration.

Market Opportunities

The market presents considerable opportunities with the increasing demand for portable, user-friendly diagnostic solutions in rural and decentralized healthcare systems. Expansion of INAAT applications into oncology, genetic testing, and personalized medicine is expected to unlock new revenue streams. Partnerships between biotechnology firms and healthcare providers for point-of-care diagnostic innovations are anticipated to accelerate adoption. Furthermore, the growing emphasis on pandemic preparedness and global health initiatives is creating avenues for wider integration of INAAT in screening programs, particularly in Asia-Pacific and Africa.

Regional Outlook

  • North America dominates the INAAT market, supported by advanced healthcare infrastructure, strong R&D pipelines, and high adoption of molecular diagnostics in hospitals and laboratories.
  • Europe follows closely, with growing investments in early disease detection technologies and support from regulatory bodies for advanced diagnostic approvals.
  • Asia Pacific is projected to witness the fastest growth due to rising healthcare spending, increasing infectious disease burden, and greater penetration of diagnostic technologies in China, India, and Southeast Asia.
  • Latin America is also expected to expand steadily, with improved access to affordable diagnostic technologies.
  • Middle East & Africa will experience gradual growth, driven by increasing efforts to combat infectious diseases and adoption of portable diagnostic solutions in underserved regions.

Leading Companies

Prominent companies in the global isothermal nucleic acid amplification technology market include:

  • Alere, Inc.
  • bioMerieux SA
  • Eiken Chemical Co. Ltd
  • Hologic Inc. (Gen-Probe)
  • Lucigen
  • Meridian Bioscience, Inc.
  • Ustar Biotechnologies Ltd.
  • QIAGEN
  • Quidel Corporation
  • Thermo Fisher Scientific, Inc.
  • BD (Becton, Dickinson & Company)
These players are focusing on technological advancements, expanding product portfolios, and strategic collaborations to strengthen their positions in the competitive market.

Market Segmentation

By Product Type

  • Instruments
  • Reagents

By Technology

  • NASBA
  • HDA
  • LAMP
  • SDA
  • SPIA
  • NEAR
  • TMA
  • RCA
  • RPA
  • SMAP2
  • Others

By Application

  • Blood Screening
  • Infectious Disease Diagnostics
  • Cancer
  • Others

By End User

  • Hospitals
  • Central & Reference Labs
  • Others

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Isothermal Nucleic Acid Amplification Technology Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2025
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Isothermal Nucleic Acid Amplification Technology Market Outlook, 2019-2032
3.1. Global Isothermal Nucleic Acid Amplification Technology Market Outlook, by Product, Value (US$ Bn), 2019-2032
3.1.1. Key Highlights
3.1.1.1. Instruments
3.1.1.2. Reagent
3.2. Global Isothermal Nucleic Acid Amplification Technology Market Outlook, by Technology, Value (US$ Bn), 2019-2032
3.2.1. Key Highlights
3.2.1.1. NASBA
3.2.1.2. HDA
3.2.1.3. LAMP
3.2.1.4. SDA
3.2.1.5. SPIA
3.2.1.6. NEAR
3.2.1.7. TMA
3.2.1.8. RCA
3.2.1.9. RPA
3.2.1.10. SMAP2
3.2.1.11. Others
3.3. Global Isothermal Nucleic Acid Amplification Technology Market Outlook, by Application, Value (US$ Bn), 2019-2032
3.3.1. Key Highlights
3.3.1.1. Blood Screening
3.3.1.2. Infectious Disease Diagnostics
3.3.1.3. Cancer
3.3.1.4. Others
3.4. Global Isothermal Nucleic Acid Amplification Technology Market Outlook, by End User, Value (US$ Bn), 2019-2032
3.4.1. Key Highlights
3.4.1.1. Blood Screening
3.4.1.2. Infectious Disease Diagnostics
3.4.1.3. Cancer
3.4.1.4. Others
3.5. Global Isothermal Nucleic Acid Amplification Technology Market Outlook, by Region, Value (US$ Bn), 2019-2032
3.5.1. Key Highlights
3.5.1.1. North America
3.5.1.2. Europe
3.5.1.3. Asia Pacific
3.5.1.4. Latin America
3.5.1.5. Middle East & Africa
4. North America Isothermal Nucleic Acid Amplification Technology Market Outlook, 2019-2032
4.1. North America Isothermal Nucleic Acid Amplification Technology Market Outlook, by Product, Value (US$ Bn), 2019-2032
4.1.1. Key Highlights
4.1.1.1. Instruments
4.1.1.2. Reagent
4.2. North America Isothermal Nucleic Acid Amplification Technology Market Outlook, by Technology, Value (US$ Bn), 2019-2032
4.2.1. Key Highlights
4.2.1.1. NASBA
4.2.1.2. HDA
4.2.1.3. LAMP
4.2.1.4. SDA
4.2.1.5. SPIA
4.2.1.6. NEAR
4.2.1.7. TMA
4.2.1.8. RCA
4.2.1.9. RPA
4.2.1.10. SMAP2
4.2.1.11. Others
4.3. North America Isothermal Nucleic Acid Amplification Technology Market Outlook, by Application, Value (US$ Bn), 2019-2032
4.3.1. Key Highlights
4.3.1.1. Blood Screening
4.3.1.2. Infectious Disease Diagnostics
4.3.1.3. Cancer
4.3.1.4. Others
4.4. North America Isothermal Nucleic Acid Amplification Technology Market Outlook, by End User, Value (US$ Bn), 2019-2032
4.4.1. Key Highlights
4.4.1.1. Blood Screening
4.4.1.2. Infectious Disease Diagnostics
4.4.1.3. Cancer
4.4.1.4. Others
4.4.2. BPS Analysis/Market Attractiveness Analysis
4.5. North America Isothermal Nucleic Acid Amplification Technology Market Outlook, by Country, Value (US$ Bn), 2019-2032
4.5.1. Key Highlights
4.5.1.1. U.S. Isothermal Nucleic Acid Amplification Technology Market by Product, Value (US$ Bn), 2019-2032
4.5.1.2. U.S. Isothermal Nucleic Acid Amplification Technology Market by Technology, Value (US$ Bn), 2019-2032
4.5.1.3. U.S. Isothermal Nucleic Acid Amplification Technology Market by Application, Value (US$ Bn), 2019-2032
4.5.1.4. U.S. Isothermal Nucleic Acid Amplification Technology Market by End User, Value (US$ Bn), 2019-2032
4.5.1.5. Canada Isothermal Nucleic Acid Amplification Technology Market by Product, Value (US$ Bn), 2019-2032
4.5.1.6. Canada Isothermal Nucleic Acid Amplification Technology Market by Technology, Value (US$ Bn), 2019-2032
4.5.1.7. Canada Isothermal Nucleic Acid Amplification Technology Market by Application, Value (US$ Bn), 2019-2032
4.5.1.8. Canada Isothermal Nucleic Acid Amplification Technology Market by End User, Value (US$ Bn), 2019-2032
4.5.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Isothermal Nucleic Acid Amplification Technology Market Outlook, 2019-2032
5.1. Europe Isothermal Nucleic Acid Amplification Technology Market Outlook, by Product, Value (US$ Bn), 2019-2032
5.1.1. Key Highlights
5.1.1.1. Instruments
5.1.1.2. Reagent
5.2. Europe Isothermal Nucleic Acid Amplification Technology Market Outlook, by Technology, Value (US$ Bn), 2019-2032
5.2.1. Key Highlights
5.2.1.1. NASBA
5.2.1.2. HDA
5.2.1.3. LAMP
5.2.1.4. SDA
5.2.1.5. SPIA
5.2.1.6. NEAR
5.2.1.7. TMA
5.2.1.8. RCA
5.2.1.9. RPA
5.2.1.10. SMAP2
5.2.1.11. Others
5.3. Europe Isothermal Nucleic Acid Amplification Technology Market Outlook, by Application, Value (US$ Bn), 2019-2032
5.3.1. Key Highlights
5.3.1.1. Blood Screening
5.3.1.2. Infectious Disease Diagnostics
5.3.1.3. Cancer
5.3.1.4. Others
5.4. Europe Isothermal Nucleic Acid Amplification Technology Market Outlook, by End User, Value (US$ Bn), 2019-2032
5.4.1. Key Highlights
5.4.1.1. Blood Screening
5.4.1.2. Infectious Disease Diagnostics
5.4.1.3. Cancer
5.4.1.4. Others
5.4.2. BPS Analysis/Market Attractiveness Analysis
5.5. Europe Isothermal Nucleic Acid Amplification Technology Market Outlook, by Country, Value (US$ Bn), 2019-2032
5.5.1. Key Highlights
5.5.1.1. Germany Isothermal Nucleic Acid Amplification Technology Market by Product, Value (US$ Bn), 2019-2032
5.5.1.2. Germany Isothermal Nucleic Acid Amplification Technology Market by Technology, Value (US$ Bn), 2019-2032
5.5.1.3. Germany Isothermal Nucleic Acid Amplification Technology Market by Application, Value (US$ Bn), 2019-2032
5.5.1.4. Germany Isothermal Nucleic Acid Amplification Technology Market by End User, Value (US$ Bn), 2019-2032
5.5.1.5. U.K. Isothermal Nucleic Acid Amplification Technology Market by Product, Value (US$ Bn), 2019-2032
5.5.1.6. U.K. Isothermal Nucleic Acid Amplification Technology Market by Technology, Value (US$ Bn), 2019-2032
5.5.1.7. U.K. Isothermal Nucleic Acid Amplification Technology Market by Application, Value (US$ Bn), 2019-2032
5.5.1.8. U.K. Isothermal Nucleic Acid Amplification Technology Market by End User, Value (US$ Bn), 2019-2032
5.5.1.9. France Isothermal Nucleic Acid Amplification Technology Market by Product, Value (US$ Bn), 2019-2032
5.5.1.10. France Isothermal Nucleic Acid Amplification Technology Market by Technology, Value (US$ Bn), 2019-2032
5.5.1.11. France Isothermal Nucleic Acid Amplification Technology Market by Application, Value (US$ Bn), 2019-2032
5.5.1.12. France Isothermal Nucleic Acid Amplification Technology Market by End User, Value (US$ Bn), 2019-2032
5.5.1.13. Italy Isothermal Nucleic Acid Amplification Technology Market by Product, Value (US$ Bn), 2019-2032
5.5.1.14. Italy Isothermal Nucleic Acid Amplification Technology Market by Technology, Value (US$ Bn), 2019-2032
5.5.1.15. Italy Isothermal Nucleic Acid Amplification Technology Market by Application, Value (US$ Bn), 2019-2032
5.5.1.16. Italy Isothermal Nucleic Acid Amplification Technology Market by End User, Value (US$ Bn), 2019-2032
5.5.1.17. Turkey Isothermal Nucleic Acid Amplification Technology Market by Product, Value (US$ Bn), 2019-2032
5.5.1.18. Turkey Isothermal Nucleic Acid Amplification Technology Market by Technology, Value (US$ Bn), 2019-2032
5.5.1.19. Turkey Isothermal Nucleic Acid Amplification Technology Market by Application, Value (US$ Bn), 2019-2032
5.5.1.20. Turkey Isothermal Nucleic Acid Amplification Technology Market by End User, Value (US$ Bn), 2019-2032
5.5.1.21. Russia Isothermal Nucleic Acid Amplification Technology Market by Product, Value (US$ Bn), 2019-2032
5.5.1.22. Russia Isothermal Nucleic Acid Amplification Technology Market by Technology, Value (US$ Bn), 2019-2032
5.5.1.23. Russia Isothermal Nucleic Acid Amplification Technology Market by Application, Value (US$ Bn), 2019-2032
5.5.1.24. Russia Isothermal Nucleic Acid Amplification Technology Market by End User, Value (US$ Bn), 2019-2032
5.5.1.25. Rest of Europe Isothermal Nucleic Acid Amplification Technology Market by Product, Value (US$ Bn), 2019-2032
5.5.1.26. Rest of Europe Isothermal Nucleic Acid Amplification Technology Market by Technology, Value (US$ Bn), 2019-2032
5.5.1.27. Rest of Europe Isothermal Nucleic Acid Amplification Technology Market by Application, Value (US$ Bn), 2019-2032
5.5.1.28. Rest of Europe Isothermal Nucleic Acid Amplification Technology Market by End User, Value (US$ Bn), 2019-2032
5.5.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Isothermal Nucleic Acid Amplification Technology Market Outlook, 2019-2032
6.1. Asia Pacific Isothermal Nucleic Acid Amplification Technology Market Outlook, by Product, Value (US$ Bn), 2019-2032
6.1.1. Key Highlights
6.1.1.1. Instruments
6.1.1.2. Reagent
6.2. Asia Pacific Isothermal Nucleic Acid Amplification Technology Market Outlook, by Technology, Value (US$ Bn), 2019-2032
6.2.1. Key Highlights
6.2.1.1. NASBA
6.2.1.2. HDA
6.2.1.3. LAMP
6.2.1.4. SDA
6.2.1.5. SPIA
6.2.1.6. NEAR
6.2.1.7. TMA
6.2.1.8. RCA
6.2.1.9. RPA
6.2.1.10. SMAP2
6.2.1.11. Others
6.3. Asia Pacific Isothermal Nucleic Acid Amplification Technology Market Outlook, by Application, Value (US$ Bn), 2019-2032
6.3.1. Key Highlights
6.3.1.1. Blood Screening
6.3.1.2. Infectious Disease Diagnostics
6.3.1.3. Cancer
6.3.1.4. Others
6.4. Asia Pacific Isothermal Nucleic Acid Amplification Technology Market Outlook, by End User, Value (US$ Bn), 2019-2032
6.4.1. Key Highlights
6.4.1.1. Blood Screening
6.4.1.2. Infectious Disease Diagnostics
6.4.1.3. Cancer
6.4.1.4. Others
6.4.2. BPS Analysis/Market Attractiveness Analysis
6.5. Asia Pacific Isothermal Nucleic Acid Amplification Technology Market Outlook, by Country, Value (US$ Bn), 2019-2032
6.5.1. Key Highlights
6.5.1.1. China Isothermal Nucleic Acid Amplification Technology Market by Product, Value (US$ Bn), 2019-2032
6.5.1.2. China Isothermal Nucleic Acid Amplification Technology Market by Technology, Value (US$ Bn), 2019-2032
6.5.1.3. China Isothermal Nucleic Acid Amplification Technology Market by Application, Value (US$ Bn), 2019-2032
6.5.1.4. China Isothermal Nucleic Acid Amplification Technology Market by End User, Value (US$ Bn), 2019-2032
6.5.1.5. Japan Isothermal Nucleic Acid Amplification Technology Market by Product, Value (US$ Bn), 2019-2032
6.5.1.6. Japan Isothermal Nucleic Acid Amplification Technology Market by Technology, Value (US$ Bn), 2019-2032
6.5.1.7. Japan Isothermal Nucleic Acid Amplification Technology Market by Application, Value (US$ Bn), 2019-2032
6.5.1.8. Japan Isothermal Nucleic Acid Amplification Technology Market by End User, Value (US$ Bn), 2019-2032
6.5.1.9. South Korea Isothermal Nucleic Acid Amplification Technology Market by Product, Value (US$ Bn), 2019-2032
6.5.1.10. South Korea Isothermal Nucleic Acid Amplification Technology Market by Technology, Value (US$ Bn), 2019-2032
6.5.1.11. South Korea Isothermal Nucleic Acid Amplification Technology Market by Application, Value (US$ Bn), 2019-2032
6.5.1.12. South Korea Isothermal Nucleic Acid Amplification Technology Market by End User, Value (US$ Bn), 2019-2032
6.5.1.13. India Isothermal Nucleic Acid Amplification Technology Market by Product, Value (US$ Bn), 2019-2032
6.5.1.14. India Isothermal Nucleic Acid Amplification Technology Market by Technology, Value (US$ Bn), 2019-2032
6.5.1.15. India Isothermal Nucleic Acid Amplification Technology Market by Application, Value (US$ Bn), 2019-2032
6.5.1.16. India Isothermal Nucleic Acid Amplification Technology Market by End User, Value (US$ Bn), 2019-2032
6.5.1.17. Southeast Asia Isothermal Nucleic Acid Amplification Technology Market by Product, Value (US$ Bn), 2019-2032
6.5.1.18. Southeast Asia Isothermal Nucleic Acid Amplification Technology Market by Technology, Value (US$ Bn), 2019-2032
6.5.1.19. Southeast Asia Isothermal Nucleic Acid Amplification Technology Market by Application, Value (US$ Bn), 2019-2032
6.5.1.20. Southeast Asia Isothermal Nucleic Acid Amplification Technology Market by End User, Value (US$ Bn), 2019-2032
6.5.1.21. Rest of Asia Pacific Isothermal Nucleic Acid Amplification Technology Market by Product, Value (US$ Bn), 2019-2032
6.5.1.22. Rest of Asia Pacific Isothermal Nucleic Acid Amplification Technology Market by Technology, Value (US$ Bn), 2019-2032
6.5.1.23. Rest of Asia Pacific Isothermal Nucleic Acid Amplification Technology Market by Application, Value (US$ Bn), 2019-2032
6.5.1.24. Rest of Asia Pacific Isothermal Nucleic Acid Amplification Technology Market by End User, Value (US$ Bn), 2019-2032
6.5.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Isothermal Nucleic Acid Amplification Technology Market Outlook, 2019-2032
7.1. Latin America Isothermal Nucleic Acid Amplification Technology Market Outlook, by Product, Value (US$ Bn), 2019-2032
7.1.1. Key Highlights
7.1.1.1. Instruments
7.1.1.2. Reagent
7.2. Latin America Isothermal Nucleic Acid Amplification Technology Market Outlook, by Technology, Value (US$ Bn), 2019-2032
7.2.1.1. NASBA
7.2.1.2. HDA
7.2.1.3. LAMP
7.2.1.4. SDA
7.2.1.5. SPIA
7.2.1.6. NEAR
7.2.1.7. TMA
7.2.1.8. RCA
7.2.1.9. RPA
7.2.1.10. SMAP2
7.2.1.11. Others
7.3. Latin America Isothermal Nucleic Acid Amplification Technology Market Outlook, by Application, Value (US$ Bn), 2019-2032
7.3.1. Key Highlights
7.3.1.1. Blood Screening
7.3.1.2. Infectious Disease Diagnostics
7.3.1.3. Cancer
7.3.1.4. Others
7.4. Latin America Isothermal Nucleic Acid Amplification Technology Market Outlook, by End User, Value (US$ Bn), 2019-2032
7.4.1. Key Highlights
7.4.1.1. Blood Screening
7.4.1.2. Infectious Disease Diagnostics
7.4.1.3. Cancer
7.4.1.4. Others
7.4.2. BPS Analysis/Market Attractiveness Analysis
7.5. Latin America Isothermal Nucleic Acid Amplification Technology Market Outlook, by Country, Value (US$ Bn), 2019-2032
7.5.1. Key Highlights
7.5.1.1. Brazil Isothermal Nucleic Acid Amplification Technology Market by Product, Value (US$ Bn), 2019-2032
7.5.1.2. Brazil Isothermal Nucleic Acid Amplification Technology Market by Technology, Value (US$ Bn), 2019-2032
7.5.1.3. Brazil Isothermal Nucleic Acid Amplification Technology Market by Application, Value (US$ Bn), 2019-2032
7.5.1.4. Brazil Isothermal Nucleic Acid Amplification Technology Market by End User, Value (US$ Bn), 2019-2032
7.5.1.5. Mexico Isothermal Nucleic Acid Amplification Technology Market by Product, Value (US$ Bn), 2019-2032
7.5.1.6. Mexico Isothermal Nucleic Acid Amplification Technology Market by Technology, Value (US$ Bn), 2019-2032
7.5.1.7. Mexico Isothermal Nucleic Acid Amplification Technology Market by Application, Value (US$ Bn), 2019-2032
7.5.1.8. Mexico Isothermal Nucleic Acid Amplification Technology Market by End User, Value (US$ Bn), 2019-2032
7.5.1.9. Argentina Isothermal Nucleic Acid Amplification Technology Market by Product, Value (US$ Bn), 2019-2032
7.5.1.10. Argentina Isothermal Nucleic Acid Amplification Technology Market by Technology, Value (US$ Bn), 2019-2032
7.5.1.11. Argentina Isothermal Nucleic Acid Amplification Technology Market by Application, Value (US$ Bn), 2019-2032
7.5.1.12. Argentina Isothermal Nucleic Acid Amplification Technology Market by End User, Value (US$ Bn), 2019-2032
7.5.1.13. Rest of Latin America Isothermal Nucleic Acid Amplification Technology Market by Product, Value (US$ Bn), 2019-2032
7.5.1.14. Rest of Latin America Isothermal Nucleic Acid Amplification Technology Market by Technology, Value (US$ Bn), 2019-2032
7.5.1.15. Rest of Latin America Isothermal Nucleic Acid Amplification Technology Market by Application, Value (US$ Bn), 2019-2032
7.5.1.16. Rest of Latin America Isothermal Nucleic Acid Amplification Technology Market by End User, Value (US$ Bn), 2019-2032
7.5.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market Outlook, 2019-2032
8.1. Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market Outlook, by Product, Value (US$ Bn), 2019-2032
8.1.1. Key Highlights
8.1.1.1. Instruments
8.1.1.2. Reagent
8.2. Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market Outlook, by Technology, Value (US$ Bn), 2019-2032
8.2.1. Key Highlights
8.2.1.1. NASBA
8.2.1.2. HDA
8.2.1.3. LAMP
8.2.1.4. SDA
8.2.1.5. SPIA
8.2.1.6. NEAR
8.2.1.7. TMA
8.2.1.8. RCA
8.2.1.9. RPA
8.2.1.10. SMAP2
8.2.1.11. Others
8.3. Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market Outlook, by Application, Value (US$ Bn), 2019-2032
8.3.1. Key Highlights
8.3.1.1. Blood Screening
8.3.1.2. Infectious Disease Diagnostics
8.3.1.3. Cancer
8.3.1.4. Others
8.4. Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market Outlook, by End User, Value (US$ Bn), 2019-2032
8.4.1. Key Highlights
8.4.1.1. Blood Screening
8.4.1.2. Infectious Disease Diagnostics
8.4.1.3. Cancer
8.4.1.4. Others
8.4.2. BPS Analysis/Market Attractiveness Analysis
8.5. Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market Outlook, by Country, Value (US$ Bn), 2019-2032
8.5.1. Key Highlights
8.5.1.1. GCC Isothermal Nucleic Acid Amplification Technology Market by Product, Value (US$ Bn), 2019-2032
8.5.1.2. GCC Isothermal Nucleic Acid Amplification Technology Market by Technology, Value (US$ Bn), 2019-2032
8.5.1.3. GCC Isothermal Nucleic Acid Amplification Technology Market by Application, Value (US$ Bn), 2019-2032
8.5.1.4. GCC Isothermal Nucleic Acid Amplification Technology Market by End User, Value (US$ Bn), 2019-2032
8.5.1.5. South Africa Isothermal Nucleic Acid Amplification Technology Market by Product, Value (US$ Bn), 2019-2032
8.5.1.6. South Africa Isothermal Nucleic Acid Amplification Technology Market by Technology, Value (US$ Bn), 2019-2032
8.5.1.7. South Africa Isothermal Nucleic Acid Amplification Technology Market by Application, Value (US$ Bn), 2019-2032
8.5.1.8. South Africa Isothermal Nucleic Acid Amplification Technology Market by End User, Value (US$ Bn), 2019-2032
8.5.1.9. Egypt Isothermal Nucleic Acid Amplification Technology Market by Product, Value (US$ Bn), 2019-2032
8.5.1.10. Egypt Isothermal Nucleic Acid Amplification Technology Market by Technology, Value (US$ Bn), 2019-2032
8.5.1.11. Egypt Isothermal Nucleic Acid Amplification Technology Market by Application, Value (US$ Bn), 2019-2032
8.5.1.12. Egypt Isothermal Nucleic Acid Amplification Technology Market by End User, Value (US$ Bn), 2019-2032
8.5.1.13. Nigeria Isothermal Nucleic Acid Amplification Technology Market by Product, Value (US$ Bn), 2019-2032
8.5.1.14. Nigeria Isothermal Nucleic Acid Amplification Technology Market by Technology, Value (US$ Bn), 2019-2032
8.5.1.15. Nigeria Isothermal Nucleic Acid Amplification Technology Market by Application, Value (US$ Bn), 2019-2032
8.5.1.16. Nigeria Isothermal Nucleic Acid Amplification Technology Market by End User, Value (US$ Bn), 2019-2032
8.5.1.17. Rest of Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market by Product, Value (US$ Bn), 2019-2032
8.5.1.18. Rest of Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market by Technology, Value (US$ Bn), 2019-2032
8.5.1.19. Rest of Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market by Application, Value (US$ Bn), 2019-2032
8.5.1.20. Rest of Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market by End User, Value (US$ Bn), 2019-2032
8.5.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Product vs Application Heatmap
9.2. Manufacturer vs Indication Heatmap
9.3. Company Market Share Analysis, 2024
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. Alere, Inc.
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. bioMerieux SA
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. Eiken Chemical Co. Ltd
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. Hologic Inc.(Gen-Probe)
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. Lucigen
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. Meridian Bioscience, Inc.
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. Ustar Biotechnologies Ltd.
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. QIAGEN
9.5.8.1. Company Overview
9.5.8.2. Product Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
9.5.9. Quidel Corporation
9.5.9.1. Company Overview
9.5.9.2. Product Portfolio
9.5.9.3. Financial Overview
9.5.9.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned

  • Alere, Inc.
  • bioMerieux SA
  • Eiken Chemical Co. Ltd
  • Hologic Inc.(Gen-Probe)
  • Lucigen
  • Meridian Bioscience, Inc.
  • Ustar Biotechnologies Ltd.
  • QIAGEN
  • Quidel Corporation
  • Thermo Fisher Scientific, Inc.
  • BD (Becton, Dickinson & Company)